Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818218 · ClinicalTrials.gov registry record
Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 58
- Enrollment target
NCT02818218: Completed study, sponsored by The Cleveland Clinic.
NCT02818218 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02818218 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
Consecutive patients undergoing liver transplant surgery will be included in the study. Before surgical incision, during the preanhepatic phase, during the anhepatic phase, during the postanhepatic phase and following closure of the deep fascial layer of the anterior abdominal wall simultaneous measurement of SVC diameter, SBC collapsibility index and CVP will be recorded.
Primary Outcome
Central Venous Pressure (CVP) reflects the amount of blood returning to the heart (venous return) and the ability of the heart to pump the blood into the arterial system. It was captured electronically via an automated record-keeping system. CVP were recorded by experienced anesthesiologists with expertise and qualifications in TEE at five key time points: before surgical incision, start of the preanhepatic phase, start of the anhepatic phase, start of the postanhepatic phase, and after closure
Interventions
- PROCEDURE Liver Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2020-09 |
What the finished NCT02818218 record still lists
NCT02818218 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Liver Transplant is the first listed.
NCT02818218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02818218 about?
NCT02818218 is a clinical study titled "Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation". Consecutive patients undergoing liver transplant surgery will be included in the study. Before surgical incision, during the preanhepatic phase, during the anhepatic phase, during the postanhepatic phase and following closure of the deep fascial layer of the anterior abdominal wall simultaneous meas...
What is the current status of trial NCT02818218?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-07-01. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02818218?
The interventions under investigation include: Liver Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT02818218?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI